INS and Insulin resistance: In severe metabolic disorders associated with insulin resistance, insulin fails to suppress gluconeogenesis in the liver while the induction of hepatic lipogenesis is sustained, eventually leading to both hyperglycemia and hyperlipidemia (5–9).